Cargando…

Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate

Increasing evidence suggests that the peroxisome proliferator-activated receptor γ (PPARγ), a member of the nuclear receptor superfamily, plays an important role in physiological processes in the central nervous system (CNS) and is involved in cellular metabolism and repair. Cellular damage caused b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pizcueta, Pilar, Vergara, Cristina, Emanuele, Marco, Vilalta, Anna, Rodríguez-Pascau, Laura, Martinell, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961553/ https://www.ncbi.nlm.nih.gov/pubmed/36834611 http://dx.doi.org/10.3390/ijms24043201

Ejemplares similares

PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes
por: Santambrogio, Paolo, et al.
Publicado: (2023)

Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome
por: Musokhranova, Uliana, et al.
Publicado: (2023)

Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes
por: Piątkowska-Chmiel, Iwona, et al.
Publicado: (2022)

Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES)
por: Pandolfo, Massimo, et al.
Publicado: (2022)

The peroxisome proliferator-activated receptor gamma (PPARγ) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness
por: Keledjian, Kaspar, et al.
Publicado: (2020)

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
por: , Sanjay, et al.
Publicado: (2021)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019)

Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
por: Quintão, Nara Lins Meira, et al.
Publicado: (2019)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010)

PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)

PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
por: Takahashi, Hirokazu, et al.
Publicado: (2010)

Role of Prostaglandins in Neuroinflammatory and Neurodegenerative Diseases
por: Lima, Isabel Vieira de Assis, et al.
Publicado: (2012)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
por: Ciavarella, Carmen, et al.
Publicado: (2020)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies
por: Pershadsingh, Harrihar A., et al.
Publicado: (2008)

The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
por: Tsukahara, Tamotsu
Publicado: (2012)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

Relaxation of human pulmonary arteries by PPARγ agonists
por: Kozłowska, Hanna, et al.
Publicado: (2013)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014)

PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia
por: Harnchoowong, Sarawin, et al.
Publicado: (2017)

PPARγ and Its Agonists in Chronic Kidney Disease
por: Ma, Yuhua, et al.
Publicado: (2020)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Mitochondrial Dynamics in Cancer and Neurodegenerative and Neuroinflammatory Diseases
por: Corrado, Mauro, et al.
Publicado: (2012)

Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses
por: Srinivasan, Karpagam, et al.
Publicado: (2016)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
por: Lichtor, Terry, et al.
Publicado: (2008)

New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014)

Therapeutic potential of PPARγ natural agonists in liver diseases
por: Wu, Liwei, et al.
Publicado: (2020)

Dual PPAR α/γ Agonists: Continuing Cardiac Concerns
por: Balachandran, Karthik
Publicado: (2019)

Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?
por: Zolezzi, Juan M., et al.
Publicado: (2013)

Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice
por: Barbieri, Michelangela, et al.
Publicado: (2012)

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
por: Abreu, Catarina M., et al.
Publicado: (2018)

The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases
por: Sommer, Annika, et al.
Publicado: (2017)

Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases
por: Hirschberg, Sarah, et al.
Publicado: (2019)

Purinergic–Glycinergic Interaction in Neurodegenerative and Neuroinflammatory Disorders of the Retina
por: Harsing, Laszlo G., et al.
Publicado: (2021)

Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
por: Rauf, Abdur, et al.
Publicado: (2022)

Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases
por: Jiang, Hao, et al.
Publicado: (2022)

Regulation of Glial Cell Functions by PPAR-γ Natural and Synthetic Agonists
por: Bernardo, Antonietta, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dio4nij5fbp6aq7ak8i7lk9hap